Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Analyst consensus target prices ticked higher across energy and mining names this week. The moves are modest but consistent — a signal of quiet confidence in the sector.
TRGP saw its average analyst target rise to $283.50. The midstream giant carries a $54.7bn market cap and has 19 buy ratings with zero sells. Short interest sits at just 2.1% of free float. Analysts are firmly on the same side.
DVN also got a target bump, to $61.24. Devon Energy holds a $51.3bn market cap. All 20 buy-side analysts remain positive. Short sellers have a thin 2.4% position — not a crowd betting against the stock.
Gold miner NEM moved up too, with the consensus target edging to $143.05. Newmont's market cap now stands at $117bn. Eighteen analysts back the stock. Gold's recent strength is likely driving the optimism.
Meanwhile, the medical devices sector saw a wave of recommendation removals. , , , , and all had analyst recs pulled. saw its target trimmed slightly to $389.24. The medtech cleanup may reflect post-earnings model resets rather than sentiment shifts.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
